Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Undisclosed ion channel modulator (Cure Network Dolby Acceleration Partners)
- Development stage
- Preclinical
- Lead developer
- Cure Network Dolby Acceleration Partners
- Modality
- Small Molecules
01
Overview
This preclinical small molecule program is being developed by **Cure Network Dolby Acceleration Partners (CNDAP)**, a joint venture between **Gladstone Institutes** (via Cure Network Ventures), **Dolby Family Ventures**, and **Evotec**. The program targets an unspecified ion channel that is implicated in the generation of detrimental brain rhythms and abnormal neuronal network activity. By modulating this ion channel, the therapeutic aim is to normalize pathological brain activity associated with **Alzheimer's disease** and various **neuropsychiatric conditions**. Initiated in 2015, the program represents an early-stage effort to address cognitive decline through the stabilization of neuronal circuitry.
- Other names
- Undisclosed ion channel modulatorCNDAP ion channel program
Beyond the preview
Go deeper on Undisclosed ion channel modulator (Cure Network Dolby Acceleration Partners).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Undisclosed ion channel modulator (Cure Network Dolby Acceleration Partners).